PhaseBio Pharmaceuticals (PHAS) null Earnings

9MayConfirmed
Aug 18
Oct 18
May 19
-10.45
-6.97
-3.48
0

Details

Expected EPS
-0.41
Actual EPS
-0.3
Surprise EPS
0.11
Surprise Percent
+26.83%

Description

PhaseBio Pharmaceuticals (PHAS) has reported earnings of -0.3 per share for .

0 Comments

Share your thoughts